Evidence map›Paper›PMID 35639613›Full record

ArticleMolecular biology and evolution2022

Ancestral Sequence Reconstruction of a Cytochrome P450 Family Involved in Chemical Defense Reveals the Functional Evolution of a Promiscuous, Xenobiotic-Metabolizing Enzyme in Vertebrates.

Kurt L Harris, Raine E S Thomson, Yosephine Gumulya, Gabriel Foley, Saskya E Carrera-Pacheco, Parnayan Syed, Tomasz Janosik, Ann-Sofie Sandinge, Shalini Andersson, Ulrik Jurva and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular biology and evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Oxidizable amino acids around cytochrome P450 hemes.Journal of inorganic biochemistry · 2026
    Article
  5. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Designing cytochrome P450 enzymes for use in cancer gene therapy.Frontiers in bioengineering and biotechnology · 2024
    Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Kurt L HarrisSchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Brisbane 4072, QLD, Australia.
Raine E S ThomsonSchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Brisbane 4072, QLD, Australia.
Yosephine GumulyaSchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Brisbane 4072, QLD, Australia.
Gabriel FoleySchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Brisbane 4072, QLD, Australia.
Saskya E Carrera-PachecoCentro de Investigación Biomédica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170147, Ecuador.
Parnayan SyedSchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Brisbane 4072, QLD, Australia.
Tomasz JanosikRISE Research Institutes of Sweden, Division Bioeconomy and Health, Chemical Process and Pharmaceutical Development, Södertälje, Sweden.
Ann-Sofie SandingeDMPK, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.
Shalini AnderssonDiscovery Sciences, BioPharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.
Ulrik JurvaDMPK, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.
Mikael BodénSchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Brisbane 4072, QLD, Australia.ORCID 0000-0003-3548-268X
Elizabeth M J GillamSchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Brisbane 4072, QLD, Australia.ORCID 0000-0003-0378-793X
The University of Queensland · AUAstraZeneca (Sweden) · SERISE Research Institutes of Sweden · SEUniversidad UTE · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytochrome P450 family 1 enzymes (CYP1s) are a diverse family of hemoprotein monooxygenases, which metabolize many xenobiotics including numerous environmental carcinogens. However, their historical function and evolution remain largely unstudied. Here we investigate CYP1 evolution via the reconstruction and characterization of the vertebrate CYP1 ancestors. Younger ancestors and extant forms generally demonstrated higher activity toward typical CYP1 xenobiotic and steroid substrates than older ancestors, suggesting significant diversification away from the original CYP1 function. Caffeine metabolism appears to be a recently evolved trait of the CYP1A subfamily, observed in the mammalian CYP1A lineage, and may parallel the recent evolution of caffeine synthesis in multiple separate plant species. Likewise, the aryl hydrocarbon receptor agonist, 6-formylindolo[3,2-b]carbazole (FICZ) was metabolized to a greater extent by certain younger ancestors and extant forms, suggesting that activity toward FICZ increased in specific CYP1 evolutionary branches, a process that may have occurred in parallel to the exploitation of land where UV-exposure was higher than in aquatic environments. As observed with previous reconstructions of P450 enzymes, thermostability correlated with evolutionary age; the oldest ancestor was up to 35 °C more thermostable than the extant forms, with a 10T50 (temperature at which 50% of the hemoprotein remains intact after 10 min) of 71 °C. This robustness may have facilitated evolutionary diversification of the CYP1s by buffering the destabilizing effects of mutations that conferred novel functions, a phenomenon which may also be useful in exploiting the catalytic versatility of these ancestral enzymes for commercial application as biocatalysts.

Indexed as

CaffeineXenobioticsAnimalsCytochrome P-450 CYP1A1Cytochrome P-450 Enzyme SystemMammalsVertebratesCaffeineCytochrome P-450 CYP1A1Cytochrome P-450 Enzyme SystemXenobioticsancestral sequence reconstructionCYP1A2CYP1B1cytochrome P450drug metabolismthermostability

Identifiers

PMID35639613
PMCPMC9185370
OpenAlexW4282922456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.